Cardiff Oncology Statistics
Total Valuation
CRDF has a market cap or net worth of $61.87 million. The enterprise value is $27.81 million.
| Market Cap | 61.87M |
| Enterprise Value | 27.81M |
Important Dates
The next estimated earnings date is Friday, November 20, 2026, after market close.
| Earnings Date | Nov 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CRDF has 77.80 million shares outstanding. The number of shares has increased by 15.77% in one year.
| Current Share Class | 77.80M |
| Shares Outstanding | 77.80M |
| Shares Change (YoY) | +15.77% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 3.10% |
| Owned by Institutions (%) | 24.81% |
| Float | 75.38M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 121.79 |
| Forward PS | 174.63 |
| PB Ratio | 2.05 |
| P/TBV Ratio | 2.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 54.74 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.30, with a Debt / Equity ratio of 0.02.
| Current Ratio | 3.30 |
| Quick Ratio | 3.21 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -94.08% and return on invested capital (ROIC) is -60.88%.
| Return on Equity (ROE) | -94.08% |
| Return on Assets (ROA) | -46.73% |
| Return on Invested Capital (ROIC) | -60.88% |
| Return on Capital Employed (ROCE) | -159.30% |
| Weighted Average Cost of Capital (WACC) | 12.76% |
| Revenue Per Employee | $16,387 |
| Profits Per Employee | -$1.29M |
| Employee Count | 31 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.50% in the last 52 weeks. The beta is 1.56, so CRDF's price volatility has been higher than the market average.
| Beta (5Y) | 1.56 |
| 52-Week Price Change | -64.50% |
| 50-Day Moving Average | 1.07 |
| 200-Day Moving Average | 1.39 |
| Relative Strength Index (RSI) | 35.63 |
| Average Volume (20 Days) | 412,392 |
Short Selling Information
The latest short interest is 12.12 million, so 15.58% of the outstanding shares have been sold short.
| Short Interest | 12.12M |
| Short Previous Month | 12.07M |
| Short % of Shares Out | 15.58% |
| Short % of Float | 16.08% |
| Short Ratio (days to cover) | 17.70 |
Income Statement
In the last 12 months, CRDF had revenue of $508,000 and -$40.08 million in losses. Loss per share was -$0.59.
| Revenue | 508,000 |
| Gross Profit | -34.82M |
| Operating Income | -42.27M |
| Pretax Income | -40.05M |
| Net Income | -40.08M |
| EBITDA | -41.92M |
| EBIT | -42.27M |
| Loss Per Share | -$0.59 |
Balance Sheet
The company has $34.52 million in cash and $457,000 in debt, with a net cash position of $34.06 million or $0.44 per share.
| Cash & Cash Equivalents | 34.52M |
| Total Debt | 457,000 |
| Net Cash | 34.06M |
| Net Cash Per Share | $0.44 |
| Equity (Book Value) | 26.53M |
| Book Value Per Share | 0.39 |
| Working Capital | 24.80M |
Cash Flow
In the last 12 months, operating cash flow was -$40.85 million and capital expenditures -$62,000, giving a free cash flow of -$40.92 million.
| Operating Cash Flow | -40.85M |
| Capital Expenditures | -62,000 |
| Depreciation & Amortization | 351,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -40.92M |
| FCF Per Share | -$0.53 |
Margins
| Gross Margin | n/a |
| Operating Margin | -8,320.08% |
| Pretax Margin | -7,884.06% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CRDF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -15.77% |
| Shareholder Yield | n/a |
| Earnings Yield | -74.36% |
| FCF Yield | -66.13% |
Analyst Forecast
The average price target for CRDF is $6.28, which is 690.02% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.28 |
| Price Target Difference | 690.02% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | -21.44% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on February 20, 2019. It was a reverse split with a ratio of 1:6.
| Last Split Date | Feb 20, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:6 |
Scores
CRDF has an Altman Z-Score of -11.68 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -11.68 |
| Piotroski F-Score | 1 |